Mytera 250 mg Tablet
  1. Home
  2. Pharma Products
  3. Mylan Pharmaceuticals Pvt Ltd
  4. Mytera 250 mg Tablet

Mytera 250 mg Tablet

Mytera 250 mg Tablet contains abiraterone acetate 250 mg, a hormonal anticancer medicine used in the treatment of prostate cancer. It helps reduce androgen production, which can slow the growth of prostate cancer cells. The tablet is taken orally on an empty stomach under the supervision of a qualified healthcare professional.

BUY NOW

Category

Abiraterone blocks the CYP17 enzyme involved in androgen production, reducing hormone stimulation of prostate cancer cells. It is commonly prescribed with a corticosteroid such as prednisone or prednisolone according to the treatment protocol. Regular monitoring of liver function, blood pressure, potassium levels, and fluid retention is important during therapy. Food should be avoided around the dose because it can significantly increase abiraterone exposure and the risk of adverse effects.

Technical Specification

Specification Details
Active Ingredient Abiraterone Acetate
Strength 250 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 60 or 120 Tablets
Marketer Mylan Pharmaceuticals Pvt Ltd – A Viatris Company

Product Also Known As

Mytera 250 mg Tablet, Mytera 250mg Tablet, Mytera 250 Tablet, Abiraterone Acetate 250 mg Tablet, Abiraterone Acetate 250mg Tablet, Abiraterone 250 mg Tablet, Abiraterone 250mg Anticancer Tablet